Cargando…

A case of undifferentiated carcinoma of the bladder treated by combination therapy of surgery, local radiation, and immune checkpoint inhibitors

Undifferentiated carcinoma of the bladder is a rare malignancy with a poor prognosis. We present the case of an 81-year-old woman complaining of bladder irritation. Computed tomography (CT) and magnetic resonance imaging (MRI) revealed a bulky bladder tumor, which was diagnosed as cT4aN0M0. A transu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakane, Wataru, Naito, Yushi, Morishita, Koya, Matsuo, Kazuna, Ishida, Shohei, Matsukawa, Yoshihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nagoya University 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748333/ https://www.ncbi.nlm.nih.gov/pubmed/36544596 http://dx.doi.org/10.18999/nagjms.84.4.865

Ejemplares similares

Associations among Physician–Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder
por: Izumi, Naoko, et al.
Publicado: (2022)

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response
por: Guram, Kripa, et al.
Publicado: (2018)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Undifferentiated sarcoma of bladder with sarcomatoid carcinoma: A case report
por: Tao, Xing, et al.
Publicado: (2022)

Therapeutic effect of adipose-derived regenerative cells on bladder function in rats with underactive bladder
por: Mori, Aya, et al.
Publicado: (2020)

Fatal Immune Checkpoint Inhibitor-related Pancreatitis
por: Ueno, Masayuki, et al.
Publicado: (2021)

Feasibility of the Lilium α-200 portable ultrasound bladder scanner for accurate bladder volume measurement
por: Majima, Tsuyoshi, et al.
Publicado: (2020)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

Checkpoint Inhibitors for Advanced Bladder Cancer
por: Messing, Edward M.
Publicado: (2016)

Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma
por: Hong, Christopher S., et al.
Publicado: (2021)

SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report
por: Utsumi, Takahiro, et al.
Publicado: (2022)

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use
por: Jeon, Won Jin, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
por: Rhea, Logan P, et al.
Publicado: (2021)

Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
por: Sindhu, Kunal K., et al.
Publicado: (2022)

Liver Transplantation in Locally Unresectable, Undifferentiated Embryonal Cell Sarcoma
por: Babu, Benoy I., et al.
Publicado: (2021)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer—A Review
por: van Hattum, Jons W., et al.
Publicado: (2021)

The Rationale for Post-Operative Radiation in Localized Bladder Cancer
por: Baumann, Brian C., et al.
Publicado: (2017)

Pleomorphic undifferentiated sarcoma of urinary bladder with calcified pulmonary metastasis: A rare entity
por: Mylarappa, Prasad, et al.
Publicado: (2013)

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells
por: YAMAMURO, SHUN, et al.
Publicado: (2015)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

A case of long-term complete remission of locally advanced T4 bladder cancer treated with pembrolizumab
por: Horibe, Yuki, et al.
Publicado: (2021)

Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
por: Kowalski, Emily S., et al.
Publicado: (2020)

Gene expression profiling in undifferentiated thyroid carcinoma induced by high-dose radiation
por: Bang, Hyun Soon, et al.
Publicado: (2016)

Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer
por: Tanaka, Hidekazu, et al.
Publicado: (2023)

The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer
por: Lewis, Gary D., et al.
Publicado: (2018)

Cost and Effectiveness of Decontamination Strategies in Radiation Contaminated Areas in Fukushima in Regard to External Radiation Dose
por: Yasutaka, Tetsuo, et al.
Publicado: (2013)

Undifferentiated high-grade pleomorphic sarcoma of the larynx treated with partial laringectomy()
por: Cambruzzi, Eduardo, et al.
Publicado: (2016)

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
por: Keung, Emily Z., et al.
Publicado: (2018)

High Cell Density Upregulates Calcium Oscillation by Increasing Calcium Store Content via Basal Mitogen-Activated Protein Kinase Activity
por: Morita, Mitsuhiro, et al.
Publicado: (2015)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study
por: Wei, Yongbao, et al.
Publicado: (2023)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC
por: Ishii, Hidenobu, et al.
Publicado: (2020)

Undifferentiated pleomorphic sarcoma
por: Premkumar, Jeyanthi, et al.
Publicado: (2012)

Undifferentiated pleomorphic sarcoma
por: de Paiva, Ana Carolina Gonçalves, et al.
Publicado: (2018)

Epidemiology of Undifferentiated Carcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2022)

Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_659npo592j13s39eb27tmeu9le